Olink up on platform being selected for new cohort study in China

Olink Holding AB (publ)

20/01/2022 16:37

** American depositary shares of Swedish biotech Olink
Holding AB (publ)  OLK.O  up ~17% at $15.25
    ** OLK among top pct gainers on the Nasdaq 
    ** Co's platform, Explore 3072, to be used by Sequanta
Technologies for analyzing 1,000 patient samples from a cohort
study in China  urn:newsml:reuters.com:*:nGNX89bJHp
    ** Study related to the investigation of novel markers and
therapeutic targets in common chronic diseases
    ** Sequanta is a China-based research and clinical service
provider
    ** OLK down 18.3% YTD

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))